Literature DB >> 32583508

Embarking upon atrial fibrillation management in heart failure with preserved ejection fraction: Charting a course.

Ravi B Patel1, Rod S Passman1, Sanjiv J Shah1.   

Abstract

Entities:  

Keywords:  atrial fibrillation; clinical trial; heart failure with preserved ejection fraction; left atrium

Mesh：

Year:  2020        PMID： 32583508      PMCID： PMC7719059          DOI： 10.1111/jce.14635

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN： 1045-3873


× No keyword cloud information.
  12 in total

1.  Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.

Authors:  Thomas A Zelniker; Marc P Bonaca; Remo H M Furtado; Ofri Mosenzon; Julia F Kuder; Sabina A Murphy; Deepak L Bhatt; Lawrence A Leiter; Darren K McGuire; John P H Wilding; Andrzej Budaj; Robert G Kiss; Francisco Padilla; Ingrid Gause-Nilsson; Anna Maria Langkilde; Itamar Raz; Marc S Sabatine; Stephen D Wiviott
Journal:  Circulation       Date:  2020-01-27       Impact factor: 29.690

2.  Heart Failure With Preserved, Borderline, and Reduced Ejection Fraction: 5-Year Outcomes.

Authors:  Kevin S Shah; Haolin Xu; Roland A Matsouaka; Deepak L Bhatt; Paul A Heidenreich; Adrian F Hernandez; Adam D Devore; Clyde W Yancy; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2017-11-12       Impact factor: 24.094

Review 3.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

4.  Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II).

Authors:  Natalia Berry; Laura Mauri; Ted Feldman; Jan Komtebedde; Dirk J van Veldhuisen; Scott D Solomon; Joseph M Massaro; Sanjiv J Shah
Journal:  Am Heart J       Date:  2019-11-11       Impact factor: 4.749

5.  Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study.

Authors:  Rosita Zakeri; Alanna M Chamberlain; Véronique L Roger; Margaret M Redfield
Journal:  Circulation       Date:  2013-08-01       Impact factor: 29.690

Review 6.  Therapeutic Targeting of Left Atrial Myopathy in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction.

Authors:  Ravi B Patel; Sanjiv J Shah
Journal:  JAMA Cardiol       Date:  2020-05-01       Impact factor: 14.676

7.  Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.

Authors:  Pei Zhang; Alanna M Chamberlain; David O Hodge; Cheng Cai; Pei L Xiao; Jie Han; Chen-Yang Jiang; Margaret M Redfield; Veronique L Roger; Yong-Mei Cha
Journal:  J Cardiovasc Electrophysiol       Date:  2020-07-16

8.  Atrial Fibrillation Catheter Ablation Increases the Left Atrial Pressure.

Authors:  Je-Wook Park; Hee Tae Yu; Tae-Hoon Kim; Jae-Sun Uhm; Boyoung Joung; Moon-Hyoung Lee; Chun Hwang; Hui-Nam Pak
Journal:  Circ Arrhythm Electrophysiol       Date:  2019-04

9.  Drug Targets for Heart Failure with Preserved Ejection Fraction: A Mechanistic Approach and Review of Contemporary Clinical Trials.

Authors:  Ravi B Patel; Sanjiv J Shah
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-10-08       Impact factor: 13.820

10.  Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction.

Authors:  Rajalakshmi Santhanakrishnan; Na Wang; Martin G Larson; Jared W Magnani; David D McManus; Steven A Lubitz; Patrick T Ellinor; Susan Cheng; Ramachandran S Vasan; Douglas S Lee; Thomas J Wang; Daniel Levy; Emelia J Benjamin; Jennifer E Ho
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690
View more
  1 in total

Review 1.  Left Atrial Myopathy in Atrial Fibrillation and Heart Failure: Clinical Implications, Mechanisms, and Therapeutic Targets.

Authors:  Graham Peigh; Sanjiv J Shah; Ravi B Patel
Journal:  Curr Heart Fail Rep       Date:  2021-04-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.